Navigation Links
Statement from ASH President Armand Keating, M.D., on FDA action to alleviate drug shortages
Date:2/21/2012

(WASHINGTON, February 21, 2012) The American Society of Hematology (ASH) is encouraged by the steps FDA is taking to alleviate drug shortages that have significantly affected so many patients with hematologic malignancies under our members' care. The measures announced today are consistent with the Society's recommendations to FDA, Congress, and the Obama Administration to expand the agency's authority to prevent drug shortages by requiring manufacturers to provide early notification of impending shortages and importing drugs in critical supply.

While ASH applauds the specific actions announced today, we also realize that these measures represent only a portion of a solution to a much larger problem. In addition to these steps, additional measures - such as developing a national drug registry and providing economic incentives to manufacturers to produce a steady supply of generics - must be implemented to permanently prevent shortages. Until a complete solution is in place, treatment will be delayed and care will be rationed for critically ill patients. ASH will continue to support legislative, regulatory, and policy changes that will give FDA the ability to prevent and mitigate drug shortages before they progress to crisis status.


'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
202-552-4927
American Society of Hematology
Source:Eurekalert

Page: 1

Related medicine news :

1. American Society of Hematology statement on critical methotrexate drug shortage
2. ATS issues joint statement on key issues and recommendations for critical care research
3. ACR and SBI issue statement on British Medical Journal article on effect of mammography on breast cancer death rates
4. EMAS publishes position statement about the post-reproductive health of women
5. AMP releases statement on diagnostics in drug labels
6. Radiation risks to health: A joint statement from leading scientific experts
7. ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis
8. ATS issues statement on the treatment of pulmonary fungal infections
9. IOF statement on new IOM dietary reference intakes for calcium and vitamin D
10. EMAS publishes position statements about the post-reproductive health of women
11. AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... an unparalleled clinical decision support technology, with highly adaptable algorithms, has been updated ... a patient has signs and symptoms consistent with Zikas and a travel history ...
(Date:2/11/2016)... FL (PRWEB) , ... February 11, 2016 , ... ... the commencement of a master charity program created to assist the people of ... days, working closely with nonprofit organizations and community leaders. Their hope is to ...
(Date:2/11/2016)... ... 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment to ... support of a local boy named Barrett, who has been fighting ALL leukemia for ... rally support for, all local families dealing with childhood cancer. Information on how to ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ergoFET force gauges used in physical therapy, occupational therapy and sports medicine clinics, ... resistance cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... ALEX , has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% of its original funding ... be delivered to backers starting May of this year. ... ... ... Created by NAMU, a team of biomedical engineers out of South ...
(Date:2/11/2016)... DUBLIN, February 11, 2016 Transformational M&A ... with Baxalta   --> Transformational M&A achieved through ...   --> Transformational M&A achieved through NPS ... Positioned for future growth with most robust pipeline ... Positioned for future growth with most robust pipeline in ...
(Date:2/11/2016)... 2016 Brain Cancer patients in ... at West Cancer Center . Optune™, ... inhibit cancer cell replication causing death of cancer cells, ... decade to show a significant extension in overall survival ... Currently, West Cancer Center is the only medical center ...
Breaking Medicine Technology: